Baebies defense health agency small business innovation research phase i development of a wide multiplexing, multifunctional platform for flexible diagnostics

Ended Purchase Order Awarded Last action

Contract number
HT942525P0034
Awardee
Awarding agency
Obligated
$249,849

Award facts

Opportunity
  • HQ003420RBDST Solicitation number
Contract value 100% obligated
$249,848.78 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 16 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27703, USA
Research
SBIR Program Phase I Action
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 · DHA sbir phase i development of a wide multiplexing, multifunctional platform for flexible diagnostics $0
Original award $249,849

About this award

The Defense Health Agency (DHA) has awarded a $249,848.78 Small Business Innovation Research (SBIR) Phase I contract to Baebies, Inc., a Durham, North Carolina-based medical diagnostic technology company. The contract, awarded on March 3, 2025, with an ultimate completion date of December 15, 2025, is designated as a Total Small Business set-aside and structured as a firm fixed-price purchase order. Under this phase of the SBIR program, Baebies will develop a wide multiplexing, multifunctional diagnostic platform designed to enable flexible and comprehensive testing capabilities. The work will be performed at the company's facility in Durham, NC.

Baebies, Inc. brings substantial experience in federal diagnostic research, having previously secured multiple contracts and grants from agencies including the National Institute of Allergy and Infectious Diseases (NIAID), the Centers for Disease Control and Prevention (CDC), and the Defense Health Agency. The company specializes in advanced digital microfluidic testing platforms with particular expertise in infectious disease diagnostics, point-of-care solutions, and pediatric applications. This DHA SBIR Phase I award builds on Baebies' track record of developing innovative diagnostic technologies and represents the agency's continued investment in small business innovation for defense health priorities.

Quick answers

Who was awarded contract HT942525P0034?

HT942525P0034 was awarded to Baebies, Inc. by Defense Health Agency (Department of Defense) on March 3, 2025.

How much is contract HT942525P0034 worth?

The government has obligated $249,849 on HT942525P0034.

Was contract HT942525P0034 competed?

The extent of competition for HT942525P0034 was full and open competition after exclusion of sources. The government received 16 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award